RNA epitranscriptomics represents a recently identified layer of regulation of genetic information. As the most abundant internal mRNA modification, m6A is critical for the regulation of mRNA metabolisms and impacts various biological and pathological processes.
The discovery of the fat-mass- and obesity-associated protein (FTO) as an m6A demethylase corroborates the m6A modification as a dynamic process. Recently, evidences prove that FTO is overexpressed in certain subtypes of apoptosis of human acute myeloid leukemia (AMLs) and promotes leukemogenesis. Thus, the development of effective inhibitors to target FTO's aberrant m6A demethylase activity is in urgent need for leukemia therapy.
To address this urgent issue, researchers have identified a potential therapy for the acute myeloid leukemia by targeting the oncogenic RNA demethylase FTO through a joint study. The finding was published in Cancer Cell.
Previously, the team had identified Meclofenamic Acid (MA) as a selective inhibitor of FTO demethylation over ALKBH5. However, the activity and selectivity of MA limited its uses in the study of biological functions of FTO demethylase.
After years of efforts, scientists developed successfully two selective FTO inhibitors through structure-based rational designs and chemical synthesis, namely FB23 and FB23-2, which efficiently reverse/suppress FTO-mediated aberrant epitranscriptome in AML cells.
In line with the regulation of FTO on downstream target genes, FB23 and FB23-2 treatment increased significantly the ASB2 and RARA while decreased the MYC and CEBPA abundance in an m6A modification-dependent manner in NB4 and MONOMAC6 cells.
Moreover, FB23-2 displayed a favorable pharmacokinetic profile and exhibited therapeutic efficacy in treating a patient-derived xeno-transplantation AML mouse model. Importantly, this proof-of-concept study demonstrated that small molecules targeting oncogenic FTO demethylase may be an effective therapeutic strategy for the treatment of AML.
However, due to the activity and selectivity of inhibitors, target engagement of current inhibitors needs further explorations. As FTO-mediated demethylation has also been linked to a variety of cancer types, the findings may have a broad impact on cancer therapy by targeting epitranscriptomic RNA methylation.
http://english.cas.cn/newsroom/research_news/201907/t20190709_212816.shtml
https://www.sciencedirect.com/science/article/abs/pii/S1535610819301515?via%3Dihub#abs0020
Targeting Acute Myeloid Leukemia with Small Molecule Therapy
- 1,314 views
- Added
Edited
Latest News
Wiring of the human neocortex
By newseditor
Posted 24 Apr
Abusive drugs hijack natura…
By newseditor
Posted 23 Apr
Mechanism of action of the…
By newseditor
Posted 23 Apr
Role of fat in rare neurolo…
By newseditor
Posted 23 Apr
How protein synthesis in de…
By newseditor
Posted 22 Apr
Other Top Stories
Turning off autophagy genes in myeloid cells provide protection aga…
Read more
How cells scramble to fix pores formed by microbial attacks
Read more
Modified sugar as a new antiviral treatment
Read more
How malaria parasites import sugar
Read more
Targeting autophagy to treat MERS coronavirus
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Harnessing gastrointestinal…
By newseditor
Posted 24 Apr
Sex-specific modulation of…
By newseditor
Posted 24 Apr
Exploiting pancreatic cance…
By newseditor
Posted 23 Apr
Structure of antiviral drug…
By newseditor
Posted 23 Apr
Type-I-interferon-responsiv…
By newseditor
Posted 23 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar